Moxifloxacin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Moxifloxacin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Treatment of M. tuberculosis including MDR and XDR-TB (in combination with other agents)
  • Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
  • Alternative therapy for treatment of S. pneumoniae and H. influenzae meningitis in patients who have severe penicillin allergies.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 4, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Moxifloxacin ID - 540355 A1 - Avdic,Edina,Pharm.D. AU - Pham,Paul,Pharm.D. Y1 - 2017/04/04/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540355/all/Moxifloxacin PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -